10-100235671-CAA-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_018294.6(CWF19L1):c.1466_1467del(p.Phe489TrpfsTer8) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,455,922 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
CWF19L1
NM_018294.6 frameshift
NM_018294.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.54
Genes affected
CWF19L1 (HGNC:25613): (CWF19 like cell cycle control factor 1) This gene encodes a member of the CWF19 protein family. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia-17 and mild cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0934 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 10-100235671-CAA-C is Pathogenic according to our data. Variant chr10-100235671-CAA-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 504148.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CWF19L1 | NM_018294.6 | c.1466_1467del | p.Phe489TrpfsTer8 | frameshift_variant | 13/14 | ENST00000354105.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CWF19L1 | ENST00000354105.10 | c.1466_1467del | p.Phe489TrpfsTer8 | frameshift_variant | 13/14 | 1 | NM_018294.6 | P1 | |
CWF19L1 | ENST00000478047.1 | n.1621_1622del | non_coding_transcript_exon_variant | 4/5 | 2 | ||||
CWF19L1 | ENST00000468709.5 | c.*1016_*1017del | 3_prime_UTR_variant, NMD_transcript_variant | 12/13 | 2 | ||||
CWF19L1 | ENST00000482452.5 | c.*853_*854del | 3_prime_UTR_variant, NMD_transcript_variant | 11/13 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1455922Hom.: 0 AF XY: 0.00000414 AC XY: 3AN XY: 724732
GnomAD4 exome
AF:
AC:
3
AN:
1455922
Hom.:
AF XY:
AC XY:
3
AN XY:
724732
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 17, 2018 | The c.1466_1467delTT variant in the CWF19L1 gene has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.1466_1467delTT variant causes a frameshift starting with codon Phenylalanine 489, changes this amino acid to a Tryptophan residue, and creates a premature Stop codon at position 8 of the new reading frame, denoted p.Phe489TrpfsX8. This variant is predicted to cause loss of normal protein function through protein truncation, as the last 50 amino acids are replaced with 7 incorrect amino acids. Furthermore, the c.1466_1467delTT variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.1466_1467delTT as a likely pathogenic variant. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 17, 2022 | Not expected to trigger nonsense-mediated mRNA decay Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at